3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 48.00
+1.00 (2.13%)
Oct 9, 2025, 2:59 PM CST
3D Global Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | 133.88 | 91.7 | -57.95 | -67.09 | -59.71 | -47.92 | Upgrade |
Depreciation & Amortization | 25.38 | 21.82 | 22.74 | 25.58 | 24.59 | 24.05 | Upgrade |
Other Amortization | 0.06 | 0.02 | 0.15 | 0.29 | 0.29 | 0.29 | Upgrade |
Loss (Gain) From Sale of Assets | - | -0 | - | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | 18.89 | - | - | Upgrade |
Stock-Based Compensation | 5.51 | 4.21 | 0.12 | 0.28 | 0.6 | 0.52 | Upgrade |
Provision & Write-off of Bad Debts | 0.33 | 0.21 | - | - | - | - | Upgrade |
Other Operating Activities | -9.88 | 3.1 | -0.98 | -16.08 | -1 | -0.23 | Upgrade |
Change in Accounts Receivable | -29.45 | -118.41 | -0.25 | 0.14 | 0.42 | 0.37 | Upgrade |
Change in Inventory | 5.12 | -3.45 | -0.23 | -2.49 | 0.26 | 0.04 | Upgrade |
Change in Accounts Payable | -38 | 12.75 | 1.11 | 1.56 | -0.26 | -0.22 | Upgrade |
Change in Unearned Revenue | 2.64 | -0.68 | 5.09 | 1.51 | - | - | Upgrade |
Change in Other Net Operating Assets | 1.87 | 8.38 | -1.42 | 2.93 | -1.18 | -0.12 | Upgrade |
Operating Cash Flow | 97.45 | 19.65 | -31.61 | -34.49 | -35.99 | -23.23 | Upgrade |
Capital Expenditures | -8.36 | -4.74 | -0.78 | -0.85 | -2.86 | -0.03 | Upgrade |
Sale of Property, Plant & Equipment | - | 0.05 | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -0.17 | -0.17 | - | -0.01 | -0.02 | - | Upgrade |
Investment in Securities | -440.88 | -488.54 | 33.7 | 19.9 | 55.5 | 19.8 | Upgrade |
Other Investing Activities | -1.39 | -1.09 | 0.66 | -0.85 | -0.33 | - | Upgrade |
Investing Cash Flow | -450.8 | -494.5 | 33.58 | 18.2 | 52.29 | 19.77 | Upgrade |
Long-Term Debt Repaid | - | -6.06 | -6.37 | -6.25 | -4.47 | -4.03 | Upgrade |
Net Debt Issued (Repaid) | -8.91 | -6.06 | -6.37 | -6.25 | -4.47 | -4.03 | Upgrade |
Issuance of Common Stock | 352.69 | 517.68 | 10.69 | 17.7 | - | 7.2 | Upgrade |
Repurchase of Common Stock | -2.37 | -2.37 | - | - | - | - | Upgrade |
Other Financing Activities | - | -0.11 | - | - | 0.11 | - | Upgrade |
Financing Cash Flow | 341.4 | 509.15 | 4.32 | 11.45 | -4.36 | 3.18 | Upgrade |
Net Cash Flow | -11.95 | 34.31 | 6.29 | -4.84 | 11.94 | -0.28 | Upgrade |
Free Cash Flow | 89.09 | 14.91 | -32.39 | -35.33 | -38.85 | -23.26 | Upgrade |
Free Cash Flow Margin | 27.42% | 5.61% | -156.99% | -258.98% | -350.81% | -175.38% | Upgrade |
Free Cash Flow Per Share | 1.13 | 0.21 | -0.58 | -0.64 | -0.72 | -0.43 | Upgrade |
Cash Interest Paid | 0.91 | 0.12 | 0.18 | 0.26 | 0.26 | 0.1 | Upgrade |
Cash Income Tax Paid | 0.25 | 0.09 | -0.02 | -0.06 | -0.05 | -0.05 | Upgrade |
Levered Free Cash Flow | 84.19 | -24.67 | -12.83 | -12.85 | -16.98 | -6.14 | Upgrade |
Unlevered Free Cash Flow | 84.75 | -24.59 | -12.72 | -12.7 | -16.82 | -6.07 | Upgrade |
Change in Working Capital | -57.82 | -101.41 | 4.3 | 3.64 | -0.77 | 0.06 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.